000 | 01997 a2200529 4500 | ||
---|---|---|---|
005 | 20250517010851.0 | ||
264 | 0 | _c20151110 | |
008 | 201511s 0 0 eng d | ||
022 | _a1873-460X | ||
024 | 7 |
_a10.1016/j.jdiacomp.2014.11.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHuang, Yuhao | |
245 | 0 | 0 |
_aComparative cardiovascular safety of insulin secretagogues following hospitalization for ischemic heart disease among type 2 diabetes patients: a cohort study. _h[electronic resource] |
260 |
_bJournal of diabetes and its complications _cMar 2015 |
||
300 |
_a196-202 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlberta _xepidemiology |
650 | 0 | 4 | _aBlue Cross Blue Shield Insurance Plans |
650 | 0 | 4 |
_aCarbamates _xadverse effects |
650 | 0 | 4 |
_aCardiovascular Diseases _xchemically induced |
650 | 0 | 4 | _aCohort Studies |
650 | 0 | 4 | _aDatabases, Factual |
650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
650 | 0 | 4 |
_aDiabetic Angiopathies _xchemically induced |
650 | 0 | 4 |
_aDiabetic Cardiomyopathies _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGliclazide _xadverse effects |
650 | 0 | 4 |
_aGlyburide _xadverse effects |
650 | 0 | 4 | _aHospitalization |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyocardial Ischemia _xcomplications |
650 | 0 | 4 |
_aPiperidines _xadverse effects |
650 | 0 | 4 | _aProportional Hazards Models |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aRisk |
650 | 0 | 4 | _aUniversal Health Insurance |
700 | 1 | _aAbdelmoneim, Ahmed S | |
700 | 1 | _aLight, Peter | |
700 | 1 | _aQiu, Weiyu | |
700 | 1 | _aSimpson, Scot H | |
773 | 0 |
_tJournal of diabetes and its complications _gvol. 29 _gno. 2 _gp. 196-202 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jdiacomp.2014.11.012 _zAvailable from publisher's website |
999 |
_c24482992 _d24482992 |